Cargando…
Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review
BACKGROUND: Ipilimumab improves survival in metastatic melanoma patients. This population frequently develops brain metastases, which have been associated with poor survival and are often treated with radiation. Therefore, outcomes following ipilimumab and radiation are of interest, especially given...
Autores principales: | Schoenfeld, Jonathan D., Mahadevan, Anand, Floyd, Scott R., Dyer, Michael A., Catalano, Paul J., Alexander, Brian M., McDermott, David F., Kaplan, Irving D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678639/ https://www.ncbi.nlm.nih.gov/pubmed/26672895 http://dx.doi.org/10.1186/s40425-015-0095-8 |
Ejemplares similares
-
The role of whole brain radiation therapy in the management of melanoma brain metastases
por: Dyer, Michael A, et al.
Publicado: (2014) -
Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab
por: Sodji, Quaovi H, et al.
Publicado: (2020) -
A Method for Combining Thin and Thick Malleable Titanium Mesh in the Repair of Cranial Defects
por: Lau, Darryl, et al.
Publicado: (2015) -
Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2020) -
A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma
por: Hakami, Osamah A, et al.
Publicado: (2019)